M48.1
Ankylosing hyperostosis [Forestier]
Clinical Classification Guidelines
Inclusion Terms
- Diffuse idiopathic skeletal hyperostosis [DISH]
Medical Intelligence & Overview
Ankylosing hyperostosis, also known as Forestier's disease or Diffuse Idiopathic Skeletal Hyperostosis (DISH), is a form of degenerative arthritis characterized by abnormal bone growth along the sides of the vertebrae. This condition involves the ossification of ligaments and surrounding tissues, leading to stiffness and reduced flexibility of the spine. Typically affecting older adults, ankylosing hyperostosis can sometimes cause discomfort or impair movement if the affected bones compress nearby structures.
Causes & Symptoms
Clinical Causes: Age-related degeneration of spinal ligaments and joints Genetic predisposition may play a role Metabolic conditions such as diabetes mellitus and obesity Lifestyle factors, including lack of physical activity and dietary influences Possible links to other metabolic or skeletal disorders
Key Symptoms: Stiffness in the back and neck, especially in the morning Reduced flexibility of the spine Pain or discomfort in the affected areas, which may worsen with activity Limited range of motion in the neck or back In some cases, inflammation or swelling over affected bones Rarely, compression of nerves or nearby structures leading to neurological symptoms In advanced cases, formation of bony bridges that can cause deformity or difficulty swallowing if cervical structures are involved
Diagnostic & Treatment
Diagnosis Path: Diagnosis of ankylosing hyperostosis involves a combination of clinical evaluation and imaging studies. Doctors typically review patient history and conduct a physical exam focused on spinal mobility and tenderness. Imaging tests, such as X-rays, are essential to confirm the presence of characteristic flowing calcifications along the anterior aspect of the spine's vertebral bodies. Advanced imaging like CT scans or MRI may be used to assess the extent of bone formation and any impact on surrounding tissues or nerves. Blood tests are generally not diagnostic but can help exclude other conditions.
Treatment Protocols: While there is no cure for ankylosing hyperostosis, various management strategies aim to alleviate symptoms and maintain quality of life. These may include: - Nonsteroidal anti-inflammatory drugs (NSAIDs) to reduce pain and inflammation - Physical therapy to improve flexibility and strength - Regular exercise programs tailored to individual capabilities - Maintaining proper posture to minimize strain on the spine - In some cases, corticosteroid injections may be used for localized inflammation - Surgery is rarely needed but can be considered in severe cases where nerve compression or deformity causes significant impairment Monitoring disease progression and addressing symptoms early can help mitigate complications and improve functional outcomes.
Clinical Advice & FAQs
Billing Guidance
Is M48.1 a billable ICD-10 code?
Yes, M48.1 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report M48.1?
Clinical documentation must specify the nature of Ankylosing hyperostosis [Forestier] and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
